{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "HKD", "esgPopulated": false, "market": "hk_market", "longName": "Clover Biopharmaceuticals, Ltd.", "marketState": "CLOSED", "regularMarketPrice": 1.63, "messageBoardId": "finmb_717346811", "exchange": "HKG", "shortName": "CLOVER BIO-B", "exchangeTimezoneShortName": "HKT", "exchangeTimezoneName": "Asia/Hong_Kong", "regularMarketChangePercent": -4.6783648, "gmtOffSetMilliseconds": 28800000, "fiftyTwoWeekLowChange": 0.110000014, "fiftyTwoWeekLowChangePercent": 0.07236843, "fiftyTwoWeekRange": "1.52 - 6.09", "fiftyTwoWeekHighChange": -4.46, "fiftyTwoWeekHighChangePercent": -0.7323481, "fiftyTwoWeekLow": 1.52, "fiftyTwoWeekHigh": 6.09, "earningsTimestamp": 1680001140, "earningsTimestampStart": 1680001140, "earningsTimestampEnd": 1680001140, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -2.49, "epsForward": 1.17, "epsCurrentYear": 0.46, "firstTradeDateMilliseconds": 1636075800000, "priceHint": 3, "regularMarketChange": -0.08000004, "regularMarketTime": 1683878916, "regularMarketDayHigh": 1.72, "regularMarketDayRange": "1.62 - 1.72", "regularMarketDayLow": 1.62, "regularMarketVolume": 5475000, "regularMarketPreviousClose": 1.71, "bid": 1.62, "ask": 1.63, "fullExchangeName": "HKSE", "financialCurrency": "CNY", "regularMarketOpen": 1.7, "averageDailyVolume3Month": 18361675, "averageDailyVolume10Day": 6359784, "priceEpsCurrentYear": 3.5434783, "sharesOutstanding": 1292640000, "bookValue": -0.517, "fiftyDayAverage": 1.9228, "fiftyDayAverageChange": -0.29279995, "fiftyDayAverageChangePercent": -0.1522779, "twoHundredDayAverage": 2.6405, "twoHundredDayAverageChange": -1.0105001, "twoHundredDayAverageChangePercent": -0.3826927, "marketCap": 2107003136, "forwardPE": 1.3931625, "priceToBook": -3.1528046, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "ipoExpectedDate": "2021-10-28", "averageAnalystRating": "2.5 - Buy", "tradeable": false, "cryptoTradeable": false, "symbol": "2197.HK"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Park Place", "address2": "49th Floor 1598-1601 West Nanjing Road Jing'an District", "city": "Shanghai", "zip": "200040", "country": "China", "website": "https://www.cloverbiopharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Clover Biopharmaceuticals, Ltd., a biotechnology company, engages in the research, development, and commercialization of novel vaccines and biologic therapeutic candidates. It is developing SCB-2019 (CpG 1018/Alum), a COVID-19 vaccine candidate; SCB-313, a trimeric fusion protein for the treatment of malignant ascites, malignant pleural effusions, and peritoneal carcinomatosis to address the global unmet medical need of intracavitary malignancies; SCB-219M, a human thrombopoietin receptor agonist (TPO-RA), for the treatment of chemotherapy-induced thrombocytopenia; and SCB-1001 Rabies Vaccine Candidate. The company has a collaboration and supply arrangement with Dynavax to supply its CpG 1018 adjuvant for pre-clinical studies. Clover Biopharmaceuticals, Ltd. was founded in 2007 and is headquartered in Shanghai, China.", "fullTimeEmployees": 764, "companyOfficers": [{"maxAge": 1, "name": "Dr. Peng  Liang Ph.D.", "age": 61, "title": "Founder, Chief Scientific Officer & Chairman", "yearBorn": 1961, "fiscalYear": 2022, "totalPay": {"raw": 660992, "fmt": "660.99k", "longFmt": "660,992"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Joshua G.  Liang", "age": 29, "title": "CEO & Exec. Director", "yearBorn": 1993, "fiscalYear": 2022, "totalPay": {"raw": 1174087, "fmt": "1.17M", "longFmt": "1,174,087"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Aileen  Wang", "age": 48, "title": "Chief Financial Officer", "yearBorn": 1974, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Yang  Li Ph.D.", "title": "Chief Technology Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Elaine  Qiu", "title": "Director of Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Albert  Liao", "title": "Exec. Director of Corp. Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Lily  Yang", "title": "Chief People Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Htay Htay  Han MBBS", "age": 53, "title": "Chief Medical Officer of Vaccine", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Berry  Michael Ph.D.", "age": 56, "title": "Chief Technical Operation Officer", "yearBorn": 1966, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Abigail  Bracha Ph.D.", "title": "Sr. VP of Corp. Strategy & Bus. Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}